Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Fuchs

Showing results (281-290 of 373) with videos related to

Pageof 38
Sort By:
British Journal of Haematology|August 16, 2021
Histopathological growth patterns in patients with advanced nodular lymphocyte-predominant Hodgkin lymphoma treated within the randomized HD18 study: a report from the German Hodgkin Study GroupDennis A Eichenauer, Ina Bühnen, Stefanie Kreissl, et al.
European Journal of Epidemiology|February 2, 2017
The LIFE Child study: a population-based perinatal and pediatric cohort in GermanyTanja Poulain, Ronny Baber, Mandy Vogel, et al.
The Journal of Investigative Dermatology|April 20, 2024
EGFR Inhibition by Erlotinib Rescues Desmosome Ultrastructure and Keratin Anchorage and Protects against Pemphigus Vulgaris IgG-Induced Acantholysis in Human EpidermisDesalegn Tadesse Egu, Thomas Schmitt, Nancy Ernst, et al.
JCI Insight|January 8, 2025
Intestinal mucosal mitochondrial oxidative phosphorylation worsens with cirrhosis progression and is ameliorated with fecal microbiota transplantationJing Zeng, Derrick Zhao, Grayson Way, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 6, 2013
Relapsed hodgkin lymphoma in older patients: a comprehensive analysis from the German hodgkin study groupBoris Böll, Helen Goergen, Nils Arndt, et al.
Gut|November 7, 2022
Longitudinal transkingdom gut microbial approach towards decompensation in outpatients with cirrhosisJasmohan S Bajaj, Marcela Peña-Rodriguez, Alex La Reau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trialAndreas Engert, Andreas Josting, Heinz Haverkamp, et al.
Blood|September 16, 2011
Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphomaBoris Böll, Henning Bredenfeld, Helen Görgen, et al.
The Lancet. Oncology|November 15, 2017
Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study GroupDennis A Eichenauer, Annette Plütschow, Stefanie Kreissl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social ReintegrationKarolin Behringer, Helen Goergen, Horst Müller, et al.
Pageof 38

Showing results (281-290 of 373) with videos related to

Sort By:
Pageof 38
British Journal of Haematology|August 16, 2021
Histopathological growth patterns in patients with advanced nodular lymphocyte-predominant Hodgkin lymphoma treated within the randomized HD18 study: a report from the German Hodgkin Study GroupDennis A Eichenauer, Ina Bühnen, Stefanie Kreissl, et al.
European Journal of Epidemiology|February 2, 2017
The LIFE Child study: a population-based perinatal and pediatric cohort in GermanyTanja Poulain, Ronny Baber, Mandy Vogel, et al.
The Journal of Investigative Dermatology|April 20, 2024
EGFR Inhibition by Erlotinib Rescues Desmosome Ultrastructure and Keratin Anchorage and Protects against Pemphigus Vulgaris IgG-Induced Acantholysis in Human EpidermisDesalegn Tadesse Egu, Thomas Schmitt, Nancy Ernst, et al.
JCI Insight|January 8, 2025
Intestinal mucosal mitochondrial oxidative phosphorylation worsens with cirrhosis progression and is ameliorated with fecal microbiota transplantationJing Zeng, Derrick Zhao, Grayson Way, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 6, 2013
Relapsed hodgkin lymphoma in older patients: a comprehensive analysis from the German hodgkin study groupBoris Böll, Helen Goergen, Nils Arndt, et al.
Gut|November 7, 2022
Longitudinal transkingdom gut microbial approach towards decompensation in outpatients with cirrhosisJasmohan S Bajaj, Marcela Peña-Rodriguez, Alex La Reau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trialAndreas Engert, Andreas Josting, Heinz Haverkamp, et al.
Blood|September 16, 2011
Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphomaBoris Böll, Henning Bredenfeld, Helen Görgen, et al.
The Lancet. Oncology|November 15, 2017
Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study GroupDennis A Eichenauer, Annette Plütschow, Stefanie Kreissl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social ReintegrationKarolin Behringer, Helen Goergen, Horst Müller, et al.
Pageof 38